These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25941633)

  • 21. Characterization of tafazzin splice variants from humans and fruit flies.
    Xu Y; Zhang S; Malhotra A; Edelman-Novemsky I; Ma J; Kruppa A; Cernicica C; Blais S; Neubert TA; Ren M; Schlame M
    J Biol Chem; 2009 Oct; 284(42):29230-9. PubMed ID: 19700766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enzymatic function of tafazzin.
    Xu Y; Malhotra A; Ren M; Schlame M
    J Biol Chem; 2006 Dec; 281(51):39217-24. PubMed ID: 17082194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a Novel De Novo Mutation of the TAZ Gene in a Korean Patient with Barth Syndrome.
    Yoo TY; Kim MR; Son JS; Lee R; Bae SH; Chung S; Kim KS; Seong MW; Park SS
    J Cardiovasc Ultrasound; 2016 Jun; 24(2):153-7. PubMed ID: 27358708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel intronic splice site
    Bakšienė M; Benušienė E; Morkūnienė A; Ambrozaitytė L; Utkus A; Kučinskas V
    Balkan J Med Genet; 2016 Dec; 19(2):95-100. PubMed ID: 28289596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: A Chinese child with Barth syndrome caused by a novel
    Che M; Li F; Jia Y; Liu Q; Hu J; Zhang J; Liu S
    Front Cardiovasc Med; 2024; 11():1465912. PubMed ID: 39309604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells.
    de Taffin de Tilques M; Lasserre JP; Godard F; Sardin E; Bouhier M; Le Guedard M; Kucharczyk R; Petit PX; Testet E; di Rago JP; Tribouillard-Tanvier D
    Microb Cell; 2018 Feb; 5(5):220-232. PubMed ID: 29796387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling.
    Raja V; Reynolds CA; Greenberg ML
    J Rare Dis Res Treat; 2017; 2(2):58-62. PubMed ID: 31032491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splicing mutation in
    Sivitskaya L; Danilenko N; Motuk I; Zhelev N
    Acta Myol; 2021 Jun; 40(2):88-92. PubMed ID: 34355125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal case report of Barth syndrome caused by novel
    Zhao X; Li X; Sun W; Jia JA; Yu M; Tian R
    Front Pediatr; 2022; 10():1004485. PubMed ID: 36440345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.
    Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mitochondrial quality control protein Yme1 is necessary to prevent defective mitophagy in a yeast model of Barth syndrome.
    Gaspard GJ; McMaster CR
    J Biol Chem; 2015 Apr; 290(14):9284-98. PubMed ID: 25688091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Fatica EM; DeLeonibus GA; House A; Kodger JV; Pearce RW; Shah RR; Levi L; Sandlers Y
    Metabolites; 2019 Dec; 9(12):. PubMed ID: 31861102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
    Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
    Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression.
    Jagirdar G; Elsner M; Scharf C; Simm S; Borucki K; Peter D; Lalk M; Methling K; Linnebacher M; Krohn M; Wolke C; Lendeckel U
    Front Genet; 2022; 13():931017. PubMed ID: 35957687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth Syndrome.
    Sniezek Carney O; Harris KW; Wohlfarter Y; Lee K; Butschek G; Anzmann A; Claypool SM; Hamacher-Brady A; Keller M; Vernon HJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38746168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life.
    Xu Y; Malhotra A; Claypool SM; Ren M; Schlame M
    Mitochondrion; 2015 Mar; 21():27-32. PubMed ID: 25598000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barth syndrome cardiomyopathy.
    Dudek J; Maack C
    Cardiovasc Res; 2017 Mar; 113(4):399-410. PubMed ID: 28158532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome.
    Liang Z; Schmidtke MW; Greenberg ML
    Front Mol Biosci; 2022; 9():915301. PubMed ID: 35693555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barth syndrome, a human disorder of cardiolipin metabolism.
    Schlame M; Ren M
    FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.
    Dudek J; Cheng IF; Balleininger M; Vaz FM; Streckfuss-Bömeke K; Hübscher D; Vukotic M; Wanders RJ; Rehling P; Guan K
    Stem Cell Res; 2013 Sep; 11(2):806-19. PubMed ID: 23792436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.